Evaluation of the sensitization of asthmatic patients to A.alternata, P.citrinum and A.fumigatus by IgE-immunoblotting

Document Type: Original Article


1 Associate Professor, Department of Microbiology, Karaj Branch, Islamic Azad University, Karaj, Iran

2 Ph.D of Microbiology, Department of Mycology, College of Basic Sciences, Qom Branch, Islamic Azad University, Qom, Iran

3 Assistant Professor, Department of Microbiology, Hidaj Branch, Islamic Azad University, Hidaj, Iran

4 Ph.D of Microbiology, Department of Microbiology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran


Background: There is evidence to demonstrate an association between fungal sensitization and asthma. Several studies have shown that saprophytic fungi such as Alternaria, Penicillium and Aspergillus species are the most prevalent fungal allergens worldwide. The main purpose of this study was to compare Alternaria alternata, Penicillium citrinum and Aspergillus fumigatus allergen bands by using the same patients and controls’ sera in clinical investigations.
Methods: Forty-eight patients with asthma (23 males, 25 females) and Forty-eight healthy controls (23 males, 25 females) were collected in 2017. Glass beads and liquid nitrogen were used to disrupt the cell wall of cultured fungi. SDS-PAGE was used to isolate protein fractions. IgE immunoblotting against the patients and controls sera were performed to isolate protein bands after electrotransfering into the nitrocellulose membrane.
Results: Our findings demonstrated the most allergenic bands consist to A. alternata with 17 bands (44.7%) relative to P. citrinum and A. fumigatus, and we found that asthmatic patients in the age range of 41 to 70 years were more sensitive when compared to other age groups.
Conclusion: Our results showed that A. alternata had more power in sensitizing the patients in comparison with P. citrinum and A. fumigatus. Also, the protein bands with high molecular weight can be considered as an index of sensitizing in immunoblotting assay.



  1. Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009. 360(10): 973–984.
  2. Bracken MB, Belanger K, Cooksonn WO, Triche E, Christiani DC, Leaderer BP. Genetic and perinatal risk factors for asthma onset and severity: a review and theoretical analysis. Epidemiol Rev 2002; 24(2):176-89.
  3. Cosmi L, Maggi L, Santarlasci V, Capone M, Cardilicchia E, Frosali F, et al. Identification of a novel subset of human circulating memory CD4+ T cells that produce both IL-17A and IL-4. J Allergy Clin Immunol 2010; 125(1): 222–230.
  4. Cakebread JA, Xu Y, Grainge C, Kehagia V, Howarth PH, Holgate ST, et al. Exogenous IFN-β has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus 2011; 127(5):1148-54.
  5. Fanta CH. Asthma. N Engl J Med 2009; 360(10):1002-14.
  6. Denning DW, O’Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 2006; 27(3):615-26.
  7. Bracken MB, Belanger K, Cooksonn WO, Triche E, Christiani DC, Leaderer BP. Genetic and perinatal risk factors for asthma onset and severity: a review and theoretical analysis. Epidemiol Rev 2002; 24(2):176-89.
  8. Bush RK, Sánchez H, Geisler D. Molecular cloning of a major Alternaria alternata allergen, rAlt a2. J Allergy Clin Immunol 1999; 104(3 Pt 1):665-71.
  9. De Vouge MW, Thaker AJ, Curran IH, Zhang L, Muradia G, Rode H, et al. Isolation and expression of a cDNA clone encoding an Alternaria alternata Alt a1 subunit. Int Arch Allergy Immunol 1996; 111(4):385-95.
  10. Corren J, Busse W, Meltzer EO, Mansfield L, Bensch G, Fahrenholz J, et al. A randomized, controlled, phase 2 study of AMG 317, an IL-4Ralpha antagonist, in patients with asthma. Am J Respir Crit Care Med 2010; 181(8):788-96.
  11. Crameri R. Recombinant aspergillus fumigatus allergens from the nucleotide sequences to clinical applications. Int Arch Allergy Immunol 1998; 115(2):99-114.
  12. Knutsen AP, Bush RK, Demain JG, Denning DW, Dixit A, Fairs A, et al. Fungi and allergic lower respiratory tract diseases. J Allergy Clin Immunol 2012; 129(2):280-91.
  13. Khosravi AR, Chabavizadeh J, Shokri H, Tadjbakhsh H. Evaluation of the sensitization of poultry workers to aspergillus fumigatus and cladophilophora carrionii. J Mycol Med 2009; 19(2):104-9.
  14. Khosravi AR, Saghazadeh M, Shokri H. Detection of specific anti alternaria alternata IgE in asthmatic patients. J Mycol Med 2009; 19(3):173-7.
  15. Zanjani LS, Bakhtiari A, Sabokbar A, Khosravi AR, Bahonar A, Memarnejadian A. Sensibilisation of asthmatic patients to extracted antigens from strains of Aspergillus fumigatus, Aspergillus flavus and Aspergillus niger. J Mycol Med 2012; 22(1):58-63.
  16. Bradford MM. A rapid and sensitive method for quantization of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54.
  17. Shen HD, Tam MF, Tang RB, Chou H. Aspergillus and penicillum allergens: focus on proteases. Curr Allergy Asthma Rep 2007; 7(5):351-6.
  18. Terr AL. Are indoor molds causing a new disease? J Allergy Clin Immunol 2007; 113(2):221-6.
  19. Bisgaard H, Hermansen MN, Buchvald F, Loland L, Halkjaer LB, Bønnelykke K,et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 2007; 357(15):1487-95.